202 related articles for article (PubMed ID: 8547082)
1. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Saif MW; Hopkins JL; Gore SD
Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune phenomena in patients with myelodysplastic syndromes.
Enright H; Miller W
Leuk Lymphoma; 1997 Feb; 24(5-6):483-9. PubMed ID: 9086438
[TBL] [Abstract][Full Text] [Related]
4. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
Fain O; Braun T; Stirnemann J; Fenaux P
Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune manifestations associated with myelodysplastic syndromes.
Grignano E; Jachiet V; Fenaux P; Ades L; Fain O; Mekinian A
Ann Hematol; 2018 Nov; 97(11):2015-2023. PubMed ID: 30091023
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome associated with multiple autoimmune disorders.
Farmakis D; Polymeropoulos E; Polonifi A; Deftereos S; Giakoumi X; Floudas H; Grapsa A; Aessopos A
Clin Rheumatol; 2005 Aug; 24(4):428-30. PubMed ID: 15827686
[TBL] [Abstract][Full Text] [Related]
7. [Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)].
Bouali F; Berrah A; Si Ahmed-Bouali D; Harrieche F; Benhalima M; Hamladji RM; Arrada M
Rev Med Interne; 2005 Oct; 26(10):777-83. PubMed ID: 16203055
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
Braun T; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
[TBL] [Abstract][Full Text] [Related]
9. The relationship between myelodysplastic syndromes and autoimmune disorders.
Zhao S; Mao H; Wang H; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):311-3. PubMed ID: 12411063
[TBL] [Abstract][Full Text] [Related]
10. A case of erythema nodosum and serositis associated with myelodysplastic syndrome.
Choi JH; Ahn MJ; Park YW; Oh HS; Lee YY; Kim IS
Korean J Intern Med; 2005 Jun; 20(2):177-9. PubMed ID: 16134776
[TBL] [Abstract][Full Text] [Related]
11. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature.
Erden A; Bilgin E; Kılıç L; Sarı A; Armağan B; Büyükaşık Y; Kalyoncu U
Drug Metab Pers Ther; 2018 Jun; 33(2):105-108. PubMed ID: 29715182
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
[TBL] [Abstract][Full Text] [Related]
13. [Auto-immune diseases and cancers. Second part: auto-immune diseases complicating cancers and their treatment].
Pasquet F; Pavic M; Ninet J; Hot A
Rev Med Interne; 2014 Oct; 35(10):656-63. PubMed ID: 25106665
[TBL] [Abstract][Full Text] [Related]
14. [Myelodysplasias and systemic diseases. A non-fortuitous association].
Berthier S; Magy N; Gil H; Schneider MB; Vuitton DA; Dupond JL
Rev Med Interne; 2001 May; 22(5):428-32. PubMed ID: 11402513
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.
Giannouli S; Voulgarelis M
Expert Rev Clin Immunol; 2014 Dec; 10(12):1679-88. PubMed ID: 25308147
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune diseases and myelodysplastic syndromes.
Komrokji RS; Kulasekararaj A; Al Ali NH; Kordasti S; Bart-Smith E; Craig BM; Padron E; Zhang L; Lancet JE; Pinilla-Ibarz J; List AF; Mufti GJ; Epling-Burnette PK
Am J Hematol; 2016 May; 91(5):E280-3. PubMed ID: 26875020
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients.
Dalamaga M; Karmaniolas K; Matekovits A; Migdalis I; Papadavid E
J Eur Acad Dermatol Venereol; 2008 May; 22(5):543-8. PubMed ID: 18070024
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.
Wesner N; Drevon L; Guedon A; Fraison JB; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
Eur J Haematol; 2019 Jan; 102(1):63-69. PubMed ID: 30218579
[TBL] [Abstract][Full Text] [Related]
19. Isolated PACNS-like presentation of a systemic vasculitis complicating a myelodysplastic syndrome.
Incalzi RA; Arena V; Capelli A; Gambassi G
J Intern Med; 2004 Jun; 255(6):674-9. PubMed ID: 15147531
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome.
Williamson BT; Foltz L; Leitch HA
Hematol Rep; 2016 May; 8(2):6480. PubMed ID: 27499837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
